Publication | Closed Access

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Breast OncologyOncologySuperiority TrialClinical TrialsBreast CancerParallel Her2-negative CohortCancer TreatmentMedicineRadiation OncologyHealth Sciences